|Pharmatek’s Drug Development Risk Assessment Scorecard was designed to improve efficiency and reduce potential risk in drug development programs. The Scorecard is a quantitative approach to assessing risk in oral drug development programs with respect to Chemistry, Manufacturing, and Controls (CMC) activities. It is a tool created to help project managers identify drug program risks and provides them with a dashboard view of critical areas in the drug development process. Pharmatek’s Scorecard is based on evaluations of hundreds of different drug candidates by Pharmatek scientists over the last 12 years.
*For further information on Pharmatek’s Drug Development Risk Assessment Scorecard, or for help scoring compounds in development, download our white paper: Assessing Risk in Oral Drug Development Programs.
Take our Risk Assessment Test and measure the potential risks in your drug development program now: Drug Development Risk Assessment Scorecard.
Each drug candidate is unique. No one program can be scripted to cover every unique chemical entity. At Pharmatek, each program is developed around critical endpoints: an easily manufacturable drug product, a final dosage form that ensures good patient compliance and the company's corporate objectives.